about
Patient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision makingPatient-reported outcomes in randomised controlled trials of colorectal cancer: an analysis determining the availability of robust data to inform clinical decision-makingCross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26The value of quality of life assessment in chronic myeloid leukemia patients receiving tyrosine kinase inhibitors.The added value of propensity score matching when using health-related quality of life reference data.Improving accuracy of prognosis in patients with myelodysplastic syndromes using self-reported quality of life data. Opportunities for a new research agenda in developing prognostic models.Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer?Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study.Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease.International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancerOvercoming barriers to the implementation of patient-reported outcomes in cancer clinical trials: the PROMOTION Registry.Standards are needed for quality of life clinical trialsReassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patientsDevelopment of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13).Health related quality of life in Middle Eastern children with beta-thalassemia.Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials.Health-related quality of life in non-small-cell lung cancer: methodologic issues in randomized controlled trials.Systematic Review of Radiation Therapy Toxicity Reporting in Randomized Controlled Trials of Rectal Cancer: A Comparison of Patient-Reported Outcomes and Clinician Toxicity Reporting.Quality of life and symptom assessment in randomized clinical trials of bladder cancer: A systematic review.Systematic Review of the Side Effects Associated With Anti-HER2-Targeted Therapies Used in the Treatment of Breast Cancer, on Behalf of the EORTC Quality of Life Group.Using patient-reported health status to improve prognostic assessment in patients with acute myeloid leukemia: current challenges and future applicationsQuality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trials.The prognostic significance of patient-reported outcomes in cancer clinical trials.Health-related quality of life assessment and reported outcomes in leukaemia randomised controlled trials - a systematic review to evaluate the added value in supporting clinical decision making.Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK cancer clinical trials: the EPiC study protocol.The case for an international patient-reported outcomes measurement information system (PROMIS®) initiative.External beam radiotherapy in prostate cancer patients: short- and long-term health-related quality of life issues.Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia.Imatinib treatment in chronic myelogenous leukemia: What have we learned so far?Health-related quality of life and symptom assessment in patients with myelodysplastic syndromes.Pain management in hematological patients with major organ dysfunctions and comorbid illnesses.The prevention of oral mucositis in patients with blood cancers: current concepts and emerging landscapes.Cross-cultural development of the EORTC QLQ-SWB36: a stand-alone measure of spiritual wellbeing for palliative care patients with cancer.Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards.Tyrosine-kinase inhibitors and patient-reported outcomes in chronic myeloid leukemia: a systematic review.Systematic review of the side effects associated with tyrosine kinase inhibitors used in the treatment of gastrointestinal stromal tumours on behalf of the EORTC Quality of Life Group.Patient-reported outcomes in randomised controlled trials of gynaecological cancers: investigating methodological quality and impact on clinical decision-making.The level of patient-reported outcome reporting in randomised controlled trials of brain tumour patients: a systematic review.Health-related quality of life and symptom assessment in randomized controlled trials of patients with leukemia and myelodysplastic syndromes: What have we learned?Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice?
P50
Q26852751-C8791D2B-13D0-4C66-8B33-622524174563Q28087212-F168C306-2C9B-493F-A8CA-8A8355DECD63Q28261683-84BF307E-B852-42A4-8D50-375F7356E34FQ30240271-75C6F972-309E-48A1-B0F5-84E49C5207F8Q30641845-1FB233D9-012F-4D1F-9B29-C2EFC0DA2286Q31054529-5570FA26-5892-40F0-BFC7-FEDFFEC8C17CQ33227546-1FFB5CD2-3D31-46A1-B1A4-2E7949892729Q33311103-20948495-77DA-4C8A-9455-827AD58FE190Q33433457-F90031EF-D68A-48DC-A1DE-49A81779A0FBQ33660380-209E5399-C019-4E67-BE51-55F8367A3355Q33780250-2231D360-A7A3-40BB-AF79-EDEFA63EE8BDQ33810402-F5EE74DC-F51A-4B79-BBE4-44078132BA49Q34060932-1220512A-FD1B-4B97-90F2-25F65EF1B79EQ34273348-1A8978E1-E6D6-48B4-9F2B-DA1B5C3598C0Q34314974-2337D12F-E989-4854-AF5E-A9136F418B2AQ35041311-28D33B75-A123-406F-B3A9-62FA18AB9725Q35186787-886265C7-10CD-44BD-96FA-6A4E45C42FB4Q35661915-F791BF93-B7A6-448C-BE81-F6403B9C63FDQ35738928-C9C39239-A724-4449-A3CC-5267EC581D60Q35871467-3F4BEC5E-779B-47C0-BF47-B1C9C997ADC1Q36498336-A581202B-42C1-48D8-A89B-E532177CCDE8Q36584771-A0815140-8331-4BE7-B82B-25E4546F6846Q37070024-0954390F-79F1-4E76-9A08-493AB8CB9048Q37191785-B1880E0D-4BEF-4AF1-9C60-D1FD1A67697DQ37312458-AD290963-0652-4197-AFBB-12C4A7AD9A93Q37428027-EDF97A57-2029-442A-9859-D3FF2B80B5E7Q37609287-D6009531-140E-40F7-8E9D-285B218D5719Q37676310-2F2A5893-B1F3-4EED-B7AB-D40A4E632E9EQ37809277-5028BC72-5F1D-425F-9427-CDC49D8C45A4Q37810109-3C927D7B-3AAF-4653-82A7-0B811F959644Q37986779-D6599226-A4B6-40D4-BD67-1656D199BBB7Q38020582-94B6D24E-B421-4525-8CDA-67440705F03DQ38030448-60C152CF-5631-4874-8B99-EA27426BA89CQ38044290-75559CC0-A4AA-454A-817D-BB4D9117964EQ38062214-54E3B3DB-414A-4AED-87D7-B8F35B5E89F9Q38185231-205B1921-E6AC-405B-AD09-320B9E553B68Q38211577-9EF6D2BF-456F-4B09-89A9-BE3F636983F8Q38230773-BC1A9EB1-7C1C-40FA-8C65-F73ED3DDCEE6Q38577744-194A0F93-F5A5-473E-9881-BD5F77F87299Q38685417-FE0C8818-B2C4-4951-A21A-4AA9B8033968
P50
name
Fabio Efficace
@ast
Fabio Efficace
@en
Fabio Efficace
@nl
type
label
Fabio Efficace
@ast
Fabio Efficace
@en
Fabio Efficace
@nl
prefLabel
Fabio Efficace
@ast
Fabio Efficace
@en
Fabio Efficace
@nl
P1006
P214
P1006
P214
P31
P7859
viaf-287795411